Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

Chemical Research in Toxicology

Volumn 13, Issue 1, 2000, Pages 31-35

  Khalil, Ashraf A ^a,b   Steyn, Salome ^a   Castagnoli Jr , Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MITOCHONDRIAL ENZYME; MONOAMINE OXIDASE INHIBITOR; PYRIDINE DERIVATIVE; PYRIDINIUM DERIVATIVE;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME STRUCTURE; PLANT LEAF; POSITRON EMISSION TOMOGRAPHY; SMOKING; STRUCTURE ANALYSIS; TOBACCO;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BINDING, COMPETITIVE; CHROMATOGRAPHY, THIN LAYER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; KINETICS; MITOCHONDRIA, LIVER; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PAPIO; PLANT LEAVES; PLANTS, TOXIC; PYRIDINIUM COMPOUNDS; TOBACCO;

GYMNOMYZA SAMOENSIS; NICOTIANA TABACUM;

EID: 0033978523     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990146f     Document Type: Article

References (30)

1. Dostert, P., Strolin-Benedetti, M., and Tipton, K. F. (1989) Interactions of monoamine oxidase with substrates and inhibitors. Med. Res. Rev. 9, 45-89.
2. Kato, M., Katayama, T., Iwata, H., Yamamura, M., Matsuoka, Y., and Nariat, H. (1998) In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. J. Pharmacol. Exp. Ther. 284, 983-990.
3. Magyar, K., Szende, B., Lengyel, J., Tarczali, J., and Szatmary, I. (1998) The neuroprotective and neuronal rescue effects of (-)-deprenyl. J. Neural Transm., Suppl. 52, 109-123.
4. Borbe, H. O., Niebch, G., and Nickel, B. (1990) Kinetic evaluation of MAO-B activity following oral administration of selegiline and desmethylselegiline in the rat. J. Neural Transm., Suppl. 32, 131-137.
5. Findley, L. J. (1995) Selective Monoamine Oxidase-B inhibitor (Deprenyl) in Parkinson's Disease. In Therapy of Parkinson's Disease (Koller, W. C., and Paulson, G., Eds.) pp 311-319, Marcel Dekker, New York.
6. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R., Schlyer, D., Zezulkova, I., and Wolf, A. P. (1996) Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. U.S.A. 93, 14065-14069.
7. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., and Wolf, A. P. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379, 733-736.
8. Soto-Otero, R., Mendez-Alvarez, E., Riguera-Vega, R., Quinoa-Cabana, E., Sanchez-Sellero, I., and Lopez-Rivadulla, L. M. (1998) Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease. Brain Res. 802, 155-162.
9. Soto-Otero, R., Riguera-Vega, R., Mendez-Alvarez, E., Sanchez-Sellero, I., and Lopez-Rivadulla, L. M. (1996) Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's disease. Biochem. Biophys. Res. Commun. 222, 607-611.
10. Morens, D. M., Grandineti, A., Reed, D., White, L. R., and Ross, G. W. (1995) Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45, 1041-1051.
11. Carr, L. A., and Rowell, P. P. (1990) Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke. Neuropharmacology 29, 311-314.
12. Yu, P. H., and Boulton, A. A. (1987) Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sci. 41, 675-682.
13. Baron, J. A. (1986) Cigarette smoking and Parkinson's disease. Neurology 36, 1490-1496.
14. Oreland, L., Fowler, C. J., and Schalling, D. (1981) Low platelet monoamine oxidase activity in cigarette smokers. Life Sci. 29, 2511-2518.
15. Schmeltz, I., and Hoffmann, D. (1977) Nitrogen-containing compounds in tobacco and tobacco smoke. Chem. Rev. 77, 295-311.
16. Fowler, J. S., Volkow, N. D., Logan, J., Pappas, N., King, P., MacGregor, R., Shea, C., Garza, V., and Galley, S. J. (1998) An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. Life Sci. 63, 19-23.
17. Yong, V. W., and Perry, T. L. (1986) Monoamine oxidase B, smoking, and Parkinson's disease. J. Neurol. Sci. 72, 265-272.
18. Carr, L. A., and Basham, K. (1991) Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain. Life Sci. 48, 1173-1177.
19. Nimkar, S. K., Anderson, A., Rimoldi, J. M., Stanton, M., Castagnoli, K. P., Mabic, S., Wang, Y.-X., and Castagnoli, N., Jr. (1996) Synthesis and monoamine oxidase-B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives. Chem. Res. Toxicol. 9, 1013-1022.
20. Inoue, H., Castagnoli, K., Van der Schyf, C., Stéphane, M., Igarashi, K., and Castagnoli, N., Jr. (1999) Species dependent differences in the monoamine oxidase A and B catalyzed oxidation of various C-4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives. J. Pharmacol. Exp. Ther. 291, 856-864.
21. Chiba, K., Peterson, L. A., Castagnoli, K. P., Trevor, A. J., and Castagnoli, N., Jr. (1985) Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Drug Metab. Dispos. 13, 342-347.
22. Salach, J. I., and Weyler, W. (1987) Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver. Methods Enzymol. 142, 627-637.
23. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
24. Norris, R. K., and Sternhell, S. (1966) Long-range spin-spin coupling in 1,4-benzoquinones and some related compounds. Aust. J. Chem. 19, 617-627.
25. Thomson, R. H. (1987) in Naturally Occurring Quinones, III, Recent Advances, pp 127-130, Chapman and Hall, London.
26. Chamberlain, W. J., and Stedman, R. L. (1968) Composition studies on tobacco. XXVIII. 2,3,6-Trimethyl-1,4-naphthoquinone in cigarette smoke. Phytochemistry 7, 1201-1203.
27. Kimland, B., Appleton, A. J., Aasen, A. J., Roseraade, J., and Enzell, C. R. (1972) Neutral oxygen-containing volatile constituents of Greek tobacco. Phytochemistry 11, 309-316.
28. Kruber, O. (1939) Über die Trimethylnaphthaline im Steinkonlenteer. Chem. Ber. 72, 1972-1977.
29. Bergmann, E., and Bergmann, F. (1938) Synthesis and reactions of substituted α-naphthoquinones J. Org. Chem. 3, 125-136.
30. Copeland, R. A. (1996) Reversible Inhibitors. In Enzymes. A Practical Introduction to Structure, Mechanism, and Data Analysis, pp 187-223, VCH Publishers, New York.